Lonza reports CHF 3.03 billion in sales amid divestment of Capsules & Health Ingredients unit

As per the company’s Restated H1 2025 Financials, its continuing business delivered CORE EBITDA of CHF 922 million, representing a margin of 30.4%

Univar expands EMEA reach in botanical ingredients push with American Distilling partnership

The company will now distribute American Distilling’s range of natural specialty ingredients for use in cosmetics, personal care, and pharmaceutical applications across select EMEA markets

TDB supports Indigenous production of green pharma ingredients

Chennai based Bioneemtec India has received support from Technology Development Board for commercializing indigenous green chemistry technologies to produce critical pharmaceutical ingredients

Safic-Alcan expands in India with majority stake in SA Ingredients

The deal brings SAI — a key distributor serving pharmaceutical and nutraceutical manufacturers — into the Safic-Alcan Group’s expanding Asia footprint

Loopworm’s silkworm-based ingredients found carbon negative in PwC-backed study

The study was conducted by PwC India in line with ISO 14040 and ISO 14044 protocols

Lonza to sell capsules & health ingredients business for $3 billion in major strategic shift

Brenntag showcases innovations in beauty and personal care at Indonesia Cosmetic Ingredients 2025

Brenntag will showcase forward-looking formulations designed to respond to Indonesia’s evolving beauty and self-care needs

BASF sells food and health performance ingredients business to Louis Dreyfus Company

Divestment is part of BASF’s strategic portfolio optimization

Briefs: Atlas Life Sciences India and Vidhi Specialty Food Ingredients

Atlas Life Sciences (India) has successfully commenced the commercial production of API - Intermediate at its new plant at Chhatral,

Evonik partners with Safic-Alcan to boost offering of advanced food ingredients

Wider reach for nutraceuticals portfolio in Europe, Turkey and Egypt